Keynote sessions by world's most eminent researchers and Networking with Experts in the field of
Infectious DiseasesHis research interests include vaccine-preventable diseases antimicrobial drug resistance, emerging
infectious diseases, microbial ecology, and emergency preparedness planning and response.
Finally, lessons for building resilience against unpredictable catastrophes are emerging from the recent tragic tsunami in the Indian Ocean that, at last report, has killed upwards of 150,000 people, with many more injured or at risk of
infectious diseases.
The report also discusses that counterfeiting drugs and medical treatment devices is emerging as a universal concern in the Global
Infectious Disease Treatment market.
The current 992-page 27th edition has newly added sections, including key developments in combination vaccines, the 2006 AAP standards for child and adolescent immunization practices, parental refusal to vaccinate, updates on prevention of mosquitoborne infections, and updated information on emerging
infectious diseases and pathogens, including Baylisascaris, metapneumovirus, West Nile virus, coronaviruses, pertussis, tuberculosis, and pneumococcal, meningococcal, and varicella infections.
In addition, the committee proposes developing new pesticides to combat the organisms that spread
infectious diseases.
infectious disease diagnostics market will play a significant role in the dynamic IVD market.
Compared with knowledge about more conventional
infectious disease threats, knowledge about novel and emerging
infectious diseases during pregnancy is even more limited.
More general information related to emerging
infectious diseases can be found at the bottom of the main page.
Winkelstein and Reingold for their comment regarding our article on the 60 years of CDC's progress in the area of
infectious diseases.
In the United States, efforts against
infectious disease have led to huge reductions in resulting deaths, with rates in 1980 less than 5% what they were in 1900, according to an analysis published by Gregory Armstrong and colleagues from the CDC in the 6 January 1999 Journal of the American Medical Association.
OTCBB:AEMD) a pioneer in developing therapeutic devices for
infectious disease, announced today that its Chairman and CEO, James A.
